AU2002224526A1 - Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same - Google Patents
Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the sameInfo
- Publication number
- AU2002224526A1 AU2002224526A1 AU2002224526A AU2452602A AU2002224526A1 AU 2002224526 A1 AU2002224526 A1 AU 2002224526A1 AU 2002224526 A AU2002224526 A AU 2002224526A AU 2452602 A AU2452602 A AU 2452602A AU 2002224526 A1 AU2002224526 A1 AU 2002224526A1
- Authority
- AU
- Australia
- Prior art keywords
- pivaloyloxybenzenesulfonylamino
- benzoyl
- freeze
- producing
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title 2
- 239000004471 Glycine Substances 0.000 title 1
- QBIHEHITTANFEO-UHFFFAOYSA-N sodium;tetrahydrate Chemical compound O.O.O.O.[Na] QBIHEHITTANFEO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000221962 | 2000-07-24 | ||
| JP2000-221962 | 2000-07-24 | ||
| PCT/JP2001/006331 WO2002007724A1 (en) | 2000-07-24 | 2001-07-23 | FREEZE-DRIED PREPARATION OF N-[o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002224526A1 true AU2002224526A1 (en) | 2002-02-05 |
Family
ID=18716277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002224526A Abandoned AU2002224526A1 (en) | 2000-07-24 | 2001-07-23 | Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7262317B2 (ja) |
| EP (1) | EP1304106A4 (ja) |
| JP (2) | JP5070670B2 (ja) |
| KR (1) | KR100807650B1 (ja) |
| AU (1) | AU2002224526A1 (ja) |
| CA (1) | CA2416600A1 (ja) |
| WO (1) | WO2002007724A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7464012B2 (en) * | 2004-12-10 | 2008-12-09 | L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude | Simplified process simulator |
| US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0613925D0 (en) * | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| JP5170334B2 (ja) * | 2011-02-25 | 2013-03-27 | 小野薬品工業株式会社 | シベレスタットナトリウム塩又はその水和物を含有する注射用製剤 |
| KR101247137B1 (ko) * | 2011-03-23 | 2013-04-01 | 주식회사 엠씨켐 | N-[o-(p-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법 |
| US9078930B2 (en) * | 2012-04-11 | 2015-07-14 | Intezyne Technologies, Inc. | Block copolymers for stable micelles |
| US9944752B2 (en) * | 2012-04-11 | 2018-04-17 | Intezyne Technologies, Inc. | Block copolymers for stable micelles |
| CN114681435A (zh) * | 2020-12-31 | 2022-07-01 | 上海汇伦生物科技有限公司 | 吸入用药物组合物 |
| CN120241699A (zh) * | 2024-01-04 | 2025-07-04 | 上海汇伦医药股份有限公司 | N-[2-[[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰]氨基]苯甲酰]-(s)-甘氨酸或其盐的新用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089539B2 (ja) * | 1987-04-30 | 1996-01-31 | 杏林製薬株式会社 | メシル酸ガベキサ−ト製剤の製造法 |
| US4885275A (en) * | 1987-10-15 | 1989-12-05 | Eli Lilly And Company | Vancomycin-HCL solutions and the lyophilization thereof |
| KR0143565B1 (ko) | 1988-06-13 | 1998-07-15 | 사노 가즈오 | 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물. |
| JPH05194366A (ja) * | 1991-10-25 | 1993-08-03 | Ono Pharmaceut Co Ltd | グリシン誘導体・モノナトリウム塩・4水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法 |
| CA2081268A1 (en) * | 1991-10-25 | 1993-04-26 | Katsuhiro Imaki | Glycine derivative monosodium salt tetrahydrate |
| JP3193597B2 (ja) | 1995-07-28 | 2001-07-30 | 小野薬品工業株式会社 | グリシン誘導体の製造方法 |
| TW403653B (en) * | 1995-12-25 | 2000-09-01 | Otsuka Pharma Co Ltd | Dry compositions |
| US6552082B2 (en) * | 2000-06-29 | 2003-04-22 | Ono Pharmaceutical Co., Ltd. | Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof |
-
2001
- 2001-07-23 US US10/333,354 patent/US7262317B2/en not_active Expired - Fee Related
- 2001-07-23 WO PCT/JP2001/006331 patent/WO2002007724A1/ja not_active Ceased
- 2001-07-23 CA CA002416600A patent/CA2416600A1/en not_active Abandoned
- 2001-07-23 EP EP01984302A patent/EP1304106A4/en not_active Withdrawn
- 2001-07-23 JP JP2002513459A patent/JP5070670B2/ja not_active Expired - Fee Related
- 2001-07-23 AU AU2002224526A patent/AU2002224526A1/en not_active Abandoned
- 2001-07-23 KR KR1020037000993A patent/KR100807650B1/ko not_active Expired - Fee Related
-
2007
- 2007-04-26 US US11/740,756 patent/US7638556B2/en not_active Expired - Fee Related
-
2012
- 2012-06-15 JP JP2012136075A patent/JP2012167132A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2416600A1 (en) | 2003-01-20 |
| US7262317B2 (en) | 2007-08-28 |
| EP1304106A1 (en) | 2003-04-23 |
| KR100807650B1 (ko) | 2008-02-28 |
| US20070203357A1 (en) | 2007-08-30 |
| WO2002007724A1 (en) | 2002-01-31 |
| JP2012167132A (ja) | 2012-09-06 |
| KR20030016426A (ko) | 2003-02-26 |
| US20040092587A1 (en) | 2004-05-13 |
| US7638556B2 (en) | 2009-12-29 |
| JP5070670B2 (ja) | 2012-11-14 |
| EP1304106A4 (en) | 2005-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001252638A1 (en) | Process for the preparation of 2-halobenzoic acids | |
| AU2002218503A1 (en) | Powdery preparations and methods for producing the same | |
| AU2002241793A1 (en) | Process for the preparation of organoclays | |
| AU2002224526A1 (en) | Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same | |
| AU2001284385A1 (en) | An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) | |
| AU2001273761A1 (en) | Preparation of (r)-2-alkyl-3-phenylpropionic acids | |
| AU3924899A (en) | Functionalised polymers of alpha-amino acids and the method of preparation thereof | |
| AU2001246339A1 (en) | Lyophilized powder of lentinan and the process of preparation thereof | |
| AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
| AU5536599A (en) | Process for the preparation of neotame | |
| HUT77022A (hu) | Eljárás N-(foszfono-metil)-glicin előállítására | |
| AU2001242376A1 (en) | Process for the preparation of 2-hydroxy-4-methylthiobutyric acid esters | |
| AU2002234171A1 (en) | Detection of modified amino acids by mass spectrometry | |
| AU2001262077A1 (en) | Method for producing n-(phosphonomethyl)glycine | |
| GB9929570D0 (en) | Process for the preparation of para-oxadiazolylphenylboronic acids | |
| AU8580298A (en) | Artificial system for the production of infectious human papillomavirus | |
| AU7075498A (en) | Process for the preparation of trifluoroethoxyarenecarboxylic acids | |
| AU6473098A (en) | Difluoronucleoside phosphonic acids and derivatives thereof | |
| AU2001295915A1 (en) | Method of forming polypeptide particles | |
| AU2001262656A1 (en) | Process for the preparation of monolayers of particles or molecules | |
| AU2001277800A1 (en) | Process for preparing alpha-amino acids and their derivatives including phenylalanine and homophenylalanine and their intermediates | |
| AU2000261768A1 (en) | An improved process for the preparation of docetaxel | |
| AU5411099A (en) | Improved process for the preparation of salts and esters of clavulanic acid | |
| AU4398500A (en) | Process for the preparation of alpha-hydroxy acids | |
| AU2001281388A1 (en) | Amino acid-derived phosphonamidic anhydrides and methods of preparing the same |